← ImmunityBio, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss) Attributable to Parent | ($120.8m) |
($96.4m)
+20.19%
|
($96.2m)
+0.20%
|
($65.8m)
+31.63%
|
($92.4m)
-40.42%
|
($346.8m)
-275.38%
|
($416.6m)
-20.12%
|
($583.2m)
-40.00%
|
($413.6m)
+29.09%
|
($351.4m)
+15.03%
|
— | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | — | — | ($96.2m) | ($65.8m) | ($92.4m) | ($349.8m) | ($417.3m) | ($583.9m) | ($413.6m) | ($351.5m) | — | |
| Net Income (Loss) Attributable to Noncontrolling Interest | — | — | — | — | — | ($3.1m) | ($753k) | ($656k) | ($81k) | ($74k) | — | |
| Depreciation, Depletion and Amortization | $3.6m | $5.6m | $9.6m | $9.0m | $9.1m | $14.2m | $18.3m | $18.5m | $17.6m | $15.5m | $16.6m | |
| Depreciation | $1.0m | $3.3m | $7.3m | $8.4m | $9.1m | $14.2m | $16.3m | $16.5m | $15.5m | $13.4m | $16.6m | |
| Amortization of Debt Issuance Costs | $0 | — | $0 | $0 | $86.3m | $164.5m | $16.3m | $42.4m | $22.6m | $0 | — | |
| Amortization of Intangible Assets | $2.6m | $2.3m | $2.3m | $600k | — | — | — | $2.0m | $2.0m | — | — | |
| Deferred Income Tax Expense (Benefit) | ($575k) | ($497k) | ($498k) | $0 | $0 | ($8k) | ($4k) | — | — | ($139k) | ($4k) | |
| Share-based Payment Arrangement, Noncash Expense | $73.9m | $37.0m | $23.4m | $2.6m | $2.1m | $57.2m | $40.2m | $49.2m | $34.4m | $36.8m | $34.3m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | $1.1m | $1.0m | $123k | $127k | $503k | $4.1m | $616k | $3.4m | $5.5m | $2.3m | — | |
| Share-based Payment Arrangement, Expense | $73.9m | $37.0m | $23.4m | $2.6m | $2.1m | $57.2m | $40.2m | $49.2m | $34.4m | $36.8m | $34.3m | |
| Impairment of Intangible Assets (Excluding Goodwill) | — | — | — | $0 | — | $0 | $681k | $886k | $0 | $0 | — | |
| Income (Loss) from Equity Method Investments | $0 | $0 | — | $1.6m | $0 | ($803k) | ($12.1m) | ($7.5m) | $0 | $0 | — | |
| Nonoperating Income (Expense) | $3.1m | $2.2m | $1.7m | $1.9m | ($752k) | ($19.6m) | ($66.0m) | ($221.6m) | ($69.5m) | ($95.6m) | — | |
| Other Nonoperating Income (Expense) | $88k | $157k | $236k | $298k | ($1.1m) | $193k | ($736k) | ($2.2m) | ($15k) | ($2.2m) | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | — | — | — | — | — | — | — | — | $2.4m | $40.2m | ($31.3m) | |
| Increase (Decrease) in Inventories | — | — | — | — | — | — | — | — | $8.3m | $6.3m | ($11.9m) | |
| Increase (Decrease) in Accounts Payable | $888k | $150k | ($1.1m) | — | — | — | — | — | — | — | $3.2m | |
| Net Cash Provided by (Used in) Operating Activities | ($38.6m) |
($48.8m)
-26.40%
|
($63.4m)
-29.93%
|
($61.4m)
+3.19%
|
($70.5m)
-14.82%
|
($274.4m)
-289.51%
|
($337.5m)
-22.99%
|
($366.8m)
-8.67%
|
($391.2m)
-6.67%
|
($304.9m)
+22.06%
|
($281.1m)
+7.80%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $6.6m | $34.8m | $13.1m | $4.2m | $2.6m | $33.6m | $78.2m | $30.6m | $6.9m | $3.8m | ($7.4m) | |
| Gain (Loss) on Investments | — | — | — | — | — | ($4.1m) | ($3.1m) | $1.1m | $8.0m | $6.4m | $295.4m | |
| Payments to Acquire Investments | — | — | $0 | — | — | — | — | — | — | — | ($539.5m) | |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | — | — | $165.3m | $109.7m | $65.3m | $56.2m | $128.2m | $10.1m | $115.6m | $64.9m | — | |
| Unrealized Gain (Loss) on Investments | ($102k) | ($97k) | $123k | $258k | ($17k) | ($13k) | ($59k) | — | — | — | $194.0m | |
| Payments to Acquire Businesses, Net of Cash Acquired | $0 | $0 | — | — | — | — | — | — | — | — | $0 | |
| Net Cash Provided by (Used in) Investing Activities | ($113.7m) | $99.6m | $57.1m | $21.5m | ($20.6m) | ($84.9m) | $27.3m | ($30.5m) | ($12.2m) | ($149.8m) | ($276.9m) | |
| Cash flows from financing activities: | ||||||||||||
| Debt and Equity Securities, Unrealized Gain (Loss) | — | — | — | $320k | ($2.9m) | ($4.6m) | ($4.2m) | ($1.6m) | ($632k) | $0 | — | |
| Gain (Loss) on Extinguishment of Debt | $0 | $0 | — | — | $0 | $0 | $82.9m | $36.1m | $10.4m | $0 | — | |
| Payments for Repurchase of Common Stock | $15.8m | $15.2m | $228k | $501k | $0 | $0 | — | — | — | — | — | |
| Proceeds from Issuance of Common Stock | $0 | $16k | $94k | $29k | $86.3m | $164.5m | $60.4m | $0 | $0 | $5.9m | $374.7m | |
| Net Cash Provided by (Used in) Financing Activities | ($15.6m) |
($35.0m)
-124.83%
|
($771k)
+97.80%
|
$38.6m
+5105.58%
|
$87.0m
+125.36%
|
$505.4m
+481.14%
|
$233.6m
-53.78%
|
$558.3m
+139.00%
|
$281.6m
-49.56%
|
$400.2m
+42.12%
|
$496.8m
+24.12%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | — | ($21k) | ($25k) | $146.2m | ($76.3m) | $160.8m | ($121.9m) | ($54.5m) | $76.9m | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Proceeds from Stock Options Exercised | $1.4m | $1.2m | — | — | $1.2m | $5.5m | $74k | $294k | — | — | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $66k | $668k | $475k | $19k | $40k | $2.1m | $35.4m | $77.2m | $92.3m | $71.3m | — | |
| Income Taxes Paid, Net | $2k | $3k | $4k | $3k | $8k | $9k | $2k | $8k | $15k | $0 | — | |
| Additional Financial Items | ||||||||||||
| Derivative, Gain (Loss) on Derivative, Net | — | — | — | — | — | — | — | — | $13.5m | $6.4m | — | |
| Equity Securities, FV-NI, Unrealized Gain (Loss) | — | — | — | $320k | ($2.9m) | ($4.6m) | ($4.2m) | ($1.6m) | ($632k) | $0 | — | |
| Fair Value, Option, Changes in Fair Value, Gain (Loss) | — | — | — | — | — | — | — | ($36.2m) | $43.5m | ($42.8m) | — | |
| Gain (Loss) on Disposition of Assets | ($18k) | ($64k) | ($209k) | $0 | ($4k) | — | — | — | — | — | — | |
| Goodwill | — | — | — | — | — | — | — | — | $910k | $910k | $21.5m | |
| Income Tax Expense (Benefit) | ($572k) | ($493k) | ($503k) | ($97k) | $5k | $9k | $34k | ($40k) | $0 | ($135k) | — | |
| Investment Income, Interest | $5.2m | $4.2m | $2.3m | $1.6m | $1.2m | — | — | — | — | — | — | |
| Operating Expenses | $124.5m | $99.2m | $98.4m | $67.8m | $91.7m | $331.2m | $351.5m | $362.9m | $358.9m | — | — | |
| Proceeds from Contributions from Affiliates | — | — | — | — | — | $1.4m | $0 | $0 | — | — | — | |
| Realized Investment Gains (Losses) | $111k | $37k | $3k | ($4k) | ($9k) | $167k | ($122k) | $15k | ($42k) | ($292k) | — |